DNA Script wins ARPA-H funding for DNA bioproduction programme
It and GE HealthCare receive up to $26 million over four years for the FLASH programme to develop modular, automated cell-free DNA bioproduction.
See the latest news and media coverage for DNA Script. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing enzymatic DNA synthesis technologies
dnascript.comLast updated
It and GE HealthCare receive up to $26 million over four years for the FLASH programme to develop modular, automated cell-free DNA bioproduction.
The four-year FLASH program, led by GE HealthCare, develops scalable cell-free DNA bioproduction using DNA Script's enzymatic DNA synthesis and SYNTAX platform.
The deal brings its SYNTAX platform for on-demand enzymatic DNA synthesis to research labs across India.
Imperial Life Sciences will handle local sales, technical support and application expertise throughout India, extending DNA Script's global distribution network.
DNA Script, announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million in funding for a four-year initiative...
DNA Script SAS is closing a $200 million series C fundraising round, with new investors pumping in cash to push commercialization of its DNA printing...
SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its...
(Boursier.com) — DNA Script announced today that it has raised €142 million in a Series C funding round led by Coatue Management and...
Track DNA Script and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.